Introduction {#section1-2333392818788420}
============

Effective pain management requires the development and implementation of reliable, valid, and applicable instruments of pain measurement. The Global Pain Scale (GPS) is a comprehensive assessment of pain and pain-related emotions, clinic outcomes, and daily activities.^[@bibr1-2333392818788420]^ Pain management physicians frequently use it as a valuable tool for evaluation and treatment planning of interventional pain management and care for patients. This brief screening tool enables clinicians to make bedside assessment of baseline functioning and perform a repeated outcome measurement to assess change over time in both acute and chronic pain states of patients.

As a multidimensional scale, GPS represents several specific clinical and functional indicators and reflects self-reported patient outcomes associated with pain care.^[@bibr2-2333392818788420],[@bibr3-2333392818788420]^ The measurement includes the effect of pain on the patient's quality of sleep, comfort, medication consumption, mood, independence, energy, work interference, perceived control over pain, health-care utilization, and satisfaction with health care received. More specifically, the GPS assesses the patient's perception on how the pain affects their ability to complete the activities of daily living functions such as shopping, chores, exercise, bathing, dressing, social activities, mobility, stamina, driving, and sexual activity.

There are 4 subscales to measure a patient's pain, feelings, clinical outcomes, and activities. For the "pain" subscale, patient may indicate the degree of pain felt currently along with their best, worst, and average pain during the last week, as well as whether they have felt less pain in the last week. All other items required patients to agree or disagree with the given statements along an 11-point (0 through 10) Likert-type scale, anchored strongly disagree to strongly agree. The 11-point scale provides a midpoint and is familiar to people who are often asked to make a judgment from 0 to 10. The "feelings" subscale asks patients how they felt in the past week for the following emotions: depressed, anxious, afraid, hopeless, exhausted, and terrified. The "clinical outcomes" subscale asks about thoughts and behaviors related to their treatment outcomes and included items such as "During the past week I took fewer medications" and "During the past week I had more energy." The "activities" subscale asked about patients' ability to perform daily activities such as doing chores in the home and walking up or down stairs.

Global Pain Scale addresses the ceiling, floor, and average pain over the past week, as well as current pain state. In assessing the psychological impact of pain on the patient, the GPS screens of depression, anxiety, fear, hopelessness, and energy level. Although GPS was designed to capture multidimensional aspects of pain, it also can provide a single summary score that could be used to track changes as the result of a clinical intervention. The total score considers weighing the 4 subscales equally and provides a single number between 0 and 100 to describe overall pain and its effects. In practice, this could allow clinicians to see the effects of an intervention or a procedure in reducing pain, increasing mobility, or reducing the need for medication.

Purpose {#section2-2333392818788420}
=======

Research on the construct validity of GPS subscales and measurement is limited.^[@bibr2-2333392818788420]^ The validity of this important measurement instrument has yet to be demonstrated empirically. The purpose of this investigation is to examine the data collection protocols of pain measurement and evaluate the usability of clinical data from a pain management practice of 10 physicians for assessing pain management outcomes. Furthermore, psychometric properties of GPS and its subscales have yet to be examined in a longitudinal study. Ultimately, research findings may solidify the measurement validity and reliability of GPS and then guide the development of a predictive model of pain effects.

Four research questions pertaining to psychometric properties of GPS and its subscales are as follows:What are the associations between GPS and its subscales?Is GPS measurement relatively stable over time?Can the patterns and change trajectories of GPS be detected in a longitudinal study?Can the variability in the reduction of pain measured by GPS be explained by physicians?

Basic Procedures {#section3-2333392818788420}
================

We used a GPS data set of a panel of 130 patients with 4 waves of data gathered by a pain management practice in 5 clinical sites located in a metropolitan area. The data set contains the assessment records of 1945 observations or visits with limited information on patient characteristics provided. The treatment plan for each visit was not documented in the data set shared with the investigator. The only variable listed in the data file was "number of medications prescribed" for each visit. The average age of patients treated by the clinics was 59.3, with a standard deviation of 14.84.

Initially, the data were sanitized and formed a panel group of 130 patients who have completed data on 4 waves of GPS measures and other clinical information. The analytical procedures are as follows:Decompose the pain scale into 4 domains of a latent variable (pain); analyze the intercorrelations among subscales of physical pain, emotions, clinical outcome, and activities; and confirm the construct validity of GPS with 4 related subscales or domains.Form multiwaves of a panel for 130 patients by combining 2 data sets on pain measurements provided by the clinic and then filtered all the account number and service date in 2016 to get a panel data set with 2 times, 3 times, and 4 times of service or treatment at the clinic. This allow us to compare if treatment time has any statistically significant effect on the total pain score (TS) through *t* tests. Outliers were eliminated from this data set.Examine the stability or test--retest reliability of measurement for 4 domains of pain, using the subscales gathered in time 1 and time 2 visits of the panel group.Conduct a latent growth curve modeling of the 2 growth trends (the initial growth pattern as shown in the intercept and the change trajectory in the slope) and detect the pain reduction effect over time.Develop a regression model for a pain-relieving intervention including patient's age, provider (physician), and treatment time as explanatory factors.

Main Findings {#section4-2333392818788420}
=============

Correlations of 4 Domains of Pain Subscales: Physical Pain, Emotions, Clinical Outcome, and Activities {#section5-2333392818788420}
------------------------------------------------------------------------------------------------------

Global Pain Scale is assumed to be a multidimensional scale with 4 related domains or subscales. [Table 1](#table1-2333392818788420){ref-type="table"} presents the intercorrelations among 4 pain domains. The clinical aspects of pain were moderately correlated with emotional (0.632) and activity (0.690) domains of the pain scale. Physical pain was also moderately associated with clinical aspects of pain (0.589). Further analysis by using total score (TS) was done to compare the correlations for 4 waves of pain measure ([Table 2](#table2-2333392818788420){ref-type="table"}). Only moderately positive associations, ranging from 0.496 to 0.621, were found among them.

###### 

Correlation Coefficients Among 4 Pain Domains or Subscales at Time 1.^a^

![](10.1177_2333392818788420-table1)

  Subscale Score    Physical Pain 1   Emotion 1   Clinical 1   Activity 1
  ----------------- ----------------- ----------- ------------ ------------
  Physical Pain 1   1                                          
  Emotion 1         .321^a^           1                        
  Clinical 1        .589^a^           .632^a^     1            
  Activity 1        .486^a^           .477^a^     .690^a^      1

^a^ Statistically significant at .01 or lower level.

###### 

Correlation Coefficients Among 4 Waves of Total Pain Score.^a^

![](10.1177_2333392818788420-table2)

  Global Pain Scale   Total Score 1   Total Score 2   Total Score 3   Total Score 4
  ------------------- --------------- --------------- --------------- ---------------
  Total score 1       1                                               
  Total score 2       .621^a^         1                               
  Total score 3       .620^a^         .503^a^         1               
  Total score 4       .555^a^         .496^a^         .583^a^         1

^a^ Statistically significant at .01 or lower level.

The Effects of Service Time {#section6-2333392818788420}
---------------------------

Because very few patients were recipients of more than 4 times of clinical services in 2016 from the clinics, the longitudinal analysis is limited to a panel group of 130 patients who have had 4 times of pain management service, using *t* tests ([Table 3](#table3-2333392818788420){ref-type="table"}).

###### 

Four Times of Pain Management Services by Total Score (TS) for Pain Measures.

![](10.1177_2333392818788420-table3)

  One-Sample Statistics                                                                                                                     
  ----------------------- ---------------- ------------------------- ----------------- ------------------------------------------- -------- --------
  TS 1                    130              54.715                    19.1662           1.6810                                               
  TS 2                    130              50.023                    20.0112           1.7551                                               
  TS 3                    130              47.177                    21.6564           1.8994                                               
  TS 4                    130              46.988                    20.3640           1.7860                                               
  One-Sample Test                                                                                                                           
                          Test Value = 0                                                                                                    
                                                                                       95% Confidence Interval of the Difference            
  *t*                     *df*             Significance (2-Tailed)   Mean Difference   Lower                                       Upper    
  TS 1                    32.549           129                       .000              54.7154                                     51.390   58.041
  TS 2                    28.502           129                       .000              50.0231                                     46.551   53.496
  TS 3                    24.838           129                       .000              47.1769                                     43.419   50.935
  TS 4                    26.309           129                       .000              46.9885                                     43.455   50.522

[Table 3](#table3-2333392818788420){ref-type="table"} shows that the mean pain score (TS) decreases as the service time increases from 54.7, 50.0, 47.2, to 47 for service time 1 to 4, respectively. From the sample *t* test, we can also find that the mean total pain score from service time 1 to service time 4 has significantly decreased or improved.

The Stability or Test--Retest Reliability of the Pain Subscales or Domains {#section7-2333392818788420}
--------------------------------------------------------------------------

The construct validity of GPS, as a multidimensional scale, was evaluated by confirmatory factor analysis, assuming "pain" as a common factor shared by 4 related subscales of the GPS. The clinical subscale of the GPS has a much stronger correlation with GPS. Four subscales or domain are moderately strongly associated with the latent construct. We examine the stability of pain score domains, using subscales measured at time 1 (first visit) and time 2 (second visit) of the panel group. This enables us to perform a test--retest reliability analysis of 2 waves of the pain measurement as a latent construct or variable with 4 related domains of the pain scores. [Figure 1](#fig1-2333392818788420){ref-type="fig"} shows that the latent variable of pain with 4 related domains is relatively stable between 2 times of clinical visits, with a statistically significant reliability coefficient (0.56) for the latent construct measured between time 1 and time 2. The goodness-of-fit statistics (χ^2^ value of 38.45 with 16 degrees of freedom; (RMSEA) of 0.07) also demonstrate that the measurement model of GPS has demonstrated with both construct validity and test--retest reliability for a panel of 130 patients.

![Stability of pain measurement: time 1 and time 2.](10.1177_2333392818788420-fig1){#fig1-2333392818788420}

Autoregressive Model of Total Pain Scores (Time 1 Through Time 4) {#section8-2333392818788420}
-----------------------------------------------------------------

The influence of prior pain scores on latter scores is demonstrated by an autoregressive model of total pain scores when moderately strong intercorrelations among 4 waves of pain scores are shown. The best fit model is presented in [Figure 2](#fig2-2333392818788420){ref-type="fig"} with 2 correlated residuals. The goodness-of-fit statistics reveals χ^2^ value of 0.54 with 1 degree of freedom and *P* value of .46, RMSEA of 0.00, GFI of 1.00, and AGFI of 0.98. The β effects of prior scores on latter scores are 0.62 at TS2, 0.99 at TS3, and 0.92 at TS4. The findings suggest that prior pain scores are excellent predictors of latter pain scores in this study.

![An autoregressive model of total pain scores in 4 waves.](10.1177_2333392818788420-fig2){#fig2-2333392818788420}

Latent Growth Curve Model of Total Pain Scores (Time 1 Through Time 4) {#section9-2333392818788420}
----------------------------------------------------------------------

We used linear growth curve modeling of 4 waves of pain measure to demonstrate the relationship of treatment time with chronic pain. The panel data (4 waves of the measurement and subsequent outcomes) allow us to hypothesize that the service time may affect the mean pain scores. It is also expected that the treatment benefit is positively associated with treatment time; the total pain score starts at a higher level and then decreases over time ([Figure 3](#fig3-2333392818788420){ref-type="fig"}).

![Growth curve model for total scores (TS) in 4 waves of pain management treatment.](10.1177_2333392818788420-fig3){#fig3-2333392818788420}

The results of the growth curve model of pain in [Figure 3](#fig3-2333392818788420){ref-type="fig"} are summarized as follows:A negative correlation (−0.037) exists between the 2 growth latent variables (intercept and slope). It suggests that patients with higher pain scores initially would experience a slower decline in latter periods (times).The growth pattern (intercept) shows statistically significant difference from time 1 to time 4, ranging from 0.88 at time 1 to 0.82. The change trajectories of pain scores are also statistically significant, ranging from 0.00 at time 2 to 0.51 at time 4.A nonlinear model of pain scores was also explored and tested. We assume that the 4 pain scores of the panel were not linearly distributed over time. A quadratic slope factor was introduced. Similar results on estimates of intercepts and slopes were found in the quadratic growth model. The detailed model can be obtained from authors at request.An estimation equation with 4 total pain scores can be formulated with the factor score weights in [Table 4](#table4-2333392818788420){ref-type="table"}.

###### 

Factor Score Weights.

![](10.1177_2333392818788420-table4)

              TS3     TS2     TS1     TS4
  ----------- ------- ------- ------- -------
  Slope       −0.01   −0.01   −0.02   −0.01
  Intercept   0.15    0.23    0.38    0.12

For a given performance or outcome variable ($Y_{it}$), an equation can be written as follows:
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where *X~t~* refers to predictor variables and $\text{~ε}_{it}$ refers to a residual term. $\text{η}_{0i}$ is a linear combination of 3 elements: $\alpha_{0} + ~\gamma_{0}W_{i} + \text{ζ}_{01}$, where $\alpha_{0}$ is the mean, $\gamma_{0}$ is the effect of an exogenous variable ($W_{i})~on~$. $\text{η}_{0i}$ at the initial level, $\text{ζ}_{01}$ is a residual term. The slope $\text{η}_{1i}$ also has 3 elements: $\alpha_{1} + ~\gamma_{1}W_{i} + \text{ζ}_{i1}$, where $\alpha_{1}$ is the mean, $\gamma_{1}$ is the effect of an exogenous variable ($W_{i})~on.\,~\text{η}_{1i}$ at the initial level, $\text{ζ}_{i1}$ is a residual term for this equation.

From [Figure 3](#fig3-2333392818788420){ref-type="fig"}, we observe that chronic pain reduces as the treatment time increases. We can then hypothesize: when the treatment time increases, the dosage of medication-taking requirement decreases. This relationship is further examined in the following section.

A Regression Model for a Pain-Relieving Intervention {#section10-2333392818788420}
----------------------------------------------------

Four waves of treatment were analyzed to detect if the number of pain treatment increased, the medication requirement would decrease. A panel of 122 patients with the complete pain medication history is included in the analysis by *t* tests for medication taken against 4 treatment times. The mean medication measure started at 5.418, declined slightly to 4.467 at time 2, and then steadily increased to 4.500 at time 3 and 4.861 at time 4 ([Table 5](#table5-2333392818788420){ref-type="table"}).

###### 

*t* Tests of Medication (Med) Taken for 4 Treatment Times.

![](10.1177_2333392818788420-table5)

  One-Sample Statistics                                                                                                                    
  ----------------------- ---------------- ------------------------- ----------------- ------------------------------------------- ------- -------
  Med 1                   122              5.418                     3.3816            .3602                                               
  Med 2                   122              4.467                     3.3431            .3027                                               
  Med 3                   122              4.500                     3.3532            .3036                                               
  Med 4                   122              4.861                     3.5867            .3247                                               
  One-Sample Test                                                                                                                          
                          Test Value = 0                                                                                                   
                                                                                       95% Confidence Interval of the Difference           
  t                       *df*             Significance (2-Tailed)   Mean Difference   Lower                                       Upper   
  Med 1                   17.697           121                       .000              5.4180                                      4.812   6.024
  Med 2                   14.759           121                       .000              4.4672                                      3.868   5.066
  Med 3                   14.823           121                       .000              4.5000                                      3.899   5.101
  Med 4                   14.968           121                       .000              4.8607                                      4.218   5.504

The mean dosage of pain medications taken was not decreasing in a linear fashion over time, although the second through fourth time of medications had a lower dosage as compared to the first treatment visit. Further analysis of age, provider (attending physician), and treatment time as predictors was conducted.

One-way analysis of variance (ANOVA) in total pain scores of a panel by patient age was performed. There was no age effect on mean scores. Similarly, mean pain scores by attending physician was also analyzed. No statistically significant differences in mean scores by physician were found. Detailed ANOVA tables of these results can be obtained from authors upon request.

Regression analysis of mean pain scores by treatment time and physician variables was performed. [Table 6](#table6-2333392818788420){ref-type="table"} shows TS1, TS2, TS3, and attending physicians as predictors of the total pain score at time 4. No physician differences in mean pain scores of patients were statistically significant when 3 waves of pain score were included as predictors for TS4 in the regression.

###### 

Total Pain Score at Time 4 (Dependent Variable) Regressed on TS1, TS2, TS3, and Attending Physicians (Physician 1 as a Reference).^a^

![](10.1177_2333392818788420-table6)

                 Estimate   Standard Error   *t* Value   Pr (\>\|t\|)
  -------------- ---------- ---------------- ----------- --------------
  Intercept      8.90562    6.21947          1.432       0.154840
   TS 1          0.23803    0.10918          2.180       0.031239
   TS 2          0.22129    0.09363          2.363       0.019758
   TS 3          0.30957    0.08715          3.552       0.000552
  Physician 2    −6.09773   7.01306          −0.869      0.386364
  Physician 3    −4.43056   5.84432          −0.758      0.449917
  Physician 4    −1.68972   4.84867          −0.348      0.728097
  Physician 5    7.04891    7.80787          0.903       0.368489
  Physician 6    7.04662    5.89627          1.195       0.234466
  Physician 7    −1.39200   10.01857         −0.139      0.889735
  Physician 8    −0.98743   6.47929          −0.152      0.879135
  Physician 9    −2.07685   6.08280          −0.341      0.733392
  Physician 10   −2.96446   9.11039          −0.325      0.745464

^a^ Multiple *R* ^2^: 0.4536; Adjusted *R* ^2^: 0.3975; *F*-statistic: 8.093 on 12 and 117 *df*.

Discussion {#section11-2333392818788420}
==========

Four major findings in regard to our research questions are summarized and discussed. First, GPS and its subscales are moderately and positively related. The clinical subscale is the strongest domain of GPS. Confirmatory factor analysis of pain as a latent variable reveals that GPS of 130 patients has demonstrated its construct validity. Thus, the summation of subscales as an aggregate or total score does reflect important pain domains.

Second, GPS measured between the first and second visits of patients during 2016 is relatively stable. The test--retest reliability of GPS construct and its subscales is 0.56 as demonstrated in the 2-wave measurement model of pain.

Third, both autoregressive model and growth curve model of GPS in the longitudinal analysis show that pain measurement is time dependent as GPS changes over time during the pain treatment period. In analyzing GPS data of a panel of 130 patients treated by 10 physicians in their pain clinics, we found that a decreasing trend in pain scores was associated with an increasing number of treatment from time 1 to time 4 period. Patient's age and attending physician were not key explanatory variables for the variability in treatment outcome measured by the total pain score.

Fourth, the variability in GPS of 130 patients is explained by physician and number of medications prescribed. Because a limited number of personal attributes and treatment data were available from the group practice, it makes impossible to control any confounder variables statistically when the patient variability in pain is being investigated. Several limitations of this study are worthy of discussion. The limited patient data in pain management is a serious problem since it prevents us from performing more thorough analysis of the data. Because the analysis of pain data is based on a single pain management group practice, the results may not be generalizable to other pain management practices.

In recognizing the conceptual and methodological limitations of these pain data, the investigators identified following variables for future research: (1) medical history on pain, (2) timing of pain assessment and analysis, (3) predictive analytics, and (4) delineation between psychological determinants and somatization factors.

Medical History on Pain {#section12-2333392818788420}
-----------------------

Because pain is a very subjective matter, details on the psychological and mental health profile should be gathered. For instance, information on prior use of pain medications (amount, frequency, and type) or other substances should be documented. More specifically, it is imperative to document the history of substance abuse during the pain treatment period so that pain management protocols could be properly amended.

Pain Assessment and Analysis {#section13-2333392818788420}
----------------------------

Although the Global Pain Scale is useful to serve as a summary of pain experienced by a patient, additional pain measures such as cognitive, affective, behavioral, and physiological indicators should be added.^[@bibr4-2333392818788420],[@bibr5-2333392818788420]^ Further psychometric analysis of pain measures should be carefully performed with a longitudinal data set generated from multiple practices on pain management, using a confirmatory factor analysis.

Theoretical Specified Predictive Analytics {#section14-2333392818788420}
------------------------------------------

The validity of predictive models is based on the rigor of analytical approaches and theoretical frameworks used by researchers and practitioners. The predictive models should include time-dependent and time-varying predictors in the analysis. Thus, a better specified model with relevant predictor variables should be included in the future research. Pain management research requires further collaboration among scientists from multiple disciplines. It is highly recommended that a transdisciplinary approach to pain management be employed by integrating macro- or ecological correlates of pain experienced with micro- or personal factors as predictors of pain.^[@bibr6-2333392818788420]^ Thus, a decision support system based on a sound predictive model of pain measures for enhancing pain management of patients could be formulated in the future.

Delineation Between Psychological Determinants and Somatization Factors {#section15-2333392818788420}
-----------------------------------------------------------------------

The complexity of etiologies of pain requires to conduct prospective studies on pain management.^[@bibr7-2333392818788420]^ The commonly used research design such as retrospective studies could not generate specific causal models to guide pain research. Furthermore, factors such as socioeconomic status,^[@bibr8-2333392818788420]^ gender,^[@bibr9-2333392818788420][@bibr10-2333392818788420]-[@bibr11-2333392818788420]^ and coping mechanisms,^[@bibr12-2333392818788420]^ moderating or mediating the relationship between interventions and treatment outcomes of pain, should be considered in investigations.

Principal Conclusions {#section16-2333392818788420}
=====================

In this study, the investigators have presented a detailed approach to improve a pain management process. It is important to note that this study involves the use of longitudinal data to conclude a necessary observation on reduction of pain while undergoing treatment. While this conclusion is somewhat anticipated, the investigators have provided a method to the readers for conducting an effective analysis of pain management measurement. The investigators have also provided necessary parameters that could have perhaps enhanced the study and made it more effective. Overall, the investigators believe that the described study advances the science of data science analytics with respect to pain management and the process is repeatable for a general pain management clinic. Furthermore, future research on pain measurements should identify behavioral cues to trigger pain responses associated with the ailments.^[@bibr13-2333392818788420]^
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